{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:02:25Z","timestamp":1789596145071,"version":"build-2803163510"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s13346-026-02054-4","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T13:04:45Z","timestamp":1778504685000},"page":"3477-3501","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Intranasal nanoemulsion for targeted medication delivery to the brain: a novel approach to treat psychotic disorder"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9199-743X","authenticated-orcid":false,"given":"Sudishna","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoleena","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnab","family":"Bagchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjib","family":"Bahadur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"issue":"24","key":"2054_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.865590","volume":"13","author":"M Pandey","year":"2022","unstructured":"Pandey M, Jain N, Kanoujia J, Hussain Z, Gorain B. Advances and challenges in intranasal delivery of antipsychotic agents targeting the central nervous system. Front Pharmacol. 2022;13(24):865590.","journal-title":"Front Pharmacol"},{"issue":"6","key":"2054_CR2","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.7150\/thno.21254","volume":"8","author":"X Dong","year":"2018","unstructured":"Dong X. Current strategies for brain drug delivery. Theranostics. 2018;8(6):1481.","journal-title":"Theranostics"},{"key":"#cr-split#-2054_CR3.1","unstructured":"Calabrese J, Al Khalili Y. Psychosis. [Updated 2023 May 1]. In: StatPearls [Internet]. StatPearls Publishing"},{"key":"#cr-split#-2054_CR3.2","unstructured":"2024 Jan [Cited 2024 Feb 27] -. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK546579\/."},{"issue":"61","key":"2054_CR4","volume":"1","author":"S Baboota","year":"2021","unstructured":"Baboota S, Ali J. Combination antipsychotics therapy for schizophrenia and related psychotic disorders interventions: Emergence to nanotechnology and herbal drugs. Journal of Drug Delivery Science and Technology. 2021Feb;1(61):102272.","journal-title":"Journal of Drug Delivery Science and Technology"},{"issue":"2","key":"2054_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15020678","volume":"15","author":"MD Ferreira","year":"2023","unstructured":"Ferreira MD, Duarte J, Veiga F, Paiva-Santos AC, Pires PC. Nanosystems for brain targeting of antipsychotic drugs: an update on the most promising nanocarriers for increased bioavailability and therapeutic efficacy. Pharmaceutics. 2023;15(2):678.","journal-title":"Pharmaceutics"},{"issue":"10265","key":"2054_CR6","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1016\/S0140-6736(20)31544-0","volume":"396","author":"RS McIntyre","year":"2020","unstructured":"McIntyre RS, Berk M, Brietzke E, Goldstein BI, L\u00f3pez-Jaramillo C, Kessing LV, et al. Bipolar disorders. The Lancet. 2020Dec 5;396(10265):1841\u201356.","journal-title":"The Lancet"},{"issue":"1","key":"2054_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/colloids7010023","volume":"7","author":"SK Misra","year":"2023","unstructured":"Misra SK, Pathak K. Nose-to-brain targeting via nanoemulsion: significance and evidence. Colloids and Interfaces. 2023Mar 17;7(1):23.","journal-title":"Colloids and Interfaces"},{"issue":"28","key":"2054_CR8","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jconrel.2017.09.001","volume":"268","author":"AR Khan","year":"2017","unstructured":"Khan AR, Liu M, Khan MW, Zhai G. Progress in brain targeting drug delivery system by nasal route. J Control Release. 2017;268(28):364\u201389.","journal-title":"J Control Release"},{"issue":"12","key":"2054_CR9","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.3390\/pharmaceutics12121230","volume":"12","author":"S Bahadur","year":"2020","unstructured":"Bahadur S, Pardhi DM, Rautio J, Rosenholm JM, Pathak K. Intranasal nanoemulsions for direct nose-to-brain delivery of actives for CNS disorders. Pharmaceutics. 2020Dec 18;12(12):1230.","journal-title":"Pharmaceutics"},{"key":"2054_CR10","doi-asserted-by":"crossref","unstructured":"Choudhury H, Gorain B, Chatterjee B, K Mandal U, Sengupta P, K Tekade R. Pharmacokinetic and pharmacodynamic features of nanoemulsion following oral, intravenous, topical and nasal route. Curr Pharm Des. 2017;23(17):2504\u201331.","DOI":"10.2174\/1381612822666161201143600"},{"issue":"252","key":"2054_CR11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jconrel.2017.03.008","volume":"28","author":"Y Singh","year":"2017","unstructured":"Singh Y, Meher JG, Raval K, Khan FA, Chaurasia M, Jain NK, et al. Nanoemulsion: Concepts, development and applications in drug delivery. J Control Release. 2017Apr;28(252):28\u201349.","journal-title":"J Control Release"},{"issue":"12","key":"2054_CR12","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.3390\/pharmaceutics14122825","volume":"14","author":"PC Pires","year":"2022","unstructured":"Pires PC, Paiva-Santos AC, Veiga F. Nano and microemulsions for the treatment of depressive and anxiety disorders: An efficient approach to improve solubility, brain bioavailability and therapeutic efficacy. Pharmaceutics. 2022Dec 16;14(12):2825.","journal-title":"Pharmaceutics"},{"issue":"30","key":"2054_CR13","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ijpharm.2019.05.032","volume":"565","author":"B Chatterjee","year":"2019","unstructured":"Chatterjee B, Gorain B, Mohananaidu K, Sengupta P, Mandal UK, Choudhury H. Targeted drug delivery to the brain via intranasal nanoemulsion: available proof of concept and existing challenges. Int J Pharm. 2019;565(30):258\u201368.","journal-title":"Int J Pharm"},{"key":"2054_CR14","unstructured":"MedlinePlus [Internet]. Bethesda (MD): National Library of Medicine (US); Psychotic disorder; [updated 2024 July 19]. Available from: https:\/\/medlineplus.gov\/psychoticdisorders.html"},{"issue":"3","key":"2054_CR15","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1056\/NEJMra1801490","volume":"379","author":"JA Lieberman","year":"2018","unstructured":"Lieberman JA, First MB. Psychotic disorders. N Engl J Med. 2018Jul 19;379(3):270\u201380.","journal-title":"N Engl J Med"},{"key":"2054_CR16","unstructured":"World Health Organization: Mental disorders. 2022 [Cited 2024 March 12]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/mental-disorders."},{"key":"2054_CR17","doi-asserted-by":"crossref","unstructured":"Johannessen JO, Joa I. Modern understanding of psychosis: from brain disease to stress disorder. And some other important aspects of psychosis\u2026. Psychosis. 2021;13(4):289\u2013301.","DOI":"10.1080\/17522439.2021.1985162"},{"key":"2054_CR18","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington, VA: American Psychiatric Association; 2013."},{"issue":"3","key":"2054_CR19","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/wps.20997","volume":"21","author":"RS McIntyre","year":"2022","unstructured":"McIntyre RS, Alda M, Baldessarini RJ, Bauer M, Berk M, Correll CU, et al. The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management. World Psychiatry. 2022;21(3):364\u201387.","journal-title":"World Psychiatry"},{"issue":"3","key":"2054_CR20","doi-asserted-by":"publisher","first-page":"490","DOI":"10.34172\/apb.2022.052","volume":"12","author":"R Rajendran","year":"2022","unstructured":"Rajendran R, Menon KN, Nair SC. Nanotechnology approaches for enhanced CNS drug delivery in the management of schizophrenia. Adv Pharm Bull. 2022;12(3):490.","journal-title":"Adv Pharm Bull"},{"issue":"10","key":"2054_CR21","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.3390\/pharmaceutics14102174","volume":"14","author":"PC Pires","year":"2022","unstructured":"Pires PC, Paiva-Santos AC, Veiga F. Antipsychotics-Loaded Nanometric Emulsions for Brain Delivery. Pharmaceutics. 2022Oct 12;14(10):2174.","journal-title":"Pharmaceutics"},{"issue":"12","key":"2054_CR22","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.3390\/pharmaceutics14122742","volume":"14","author":"M Alberto","year":"2022","unstructured":"Alberto M, Paiva-Santos AC, Veiga F, Pires PC. Lipid and polymeric nanoparticles: successful strategies for nose-to-Brain drug delivery in the treatment of depression and anxiety disorders. Pharmaceutics. 2022Dec 8;14(12):2742.","journal-title":"Pharmaceutics"},{"key":"2054_CR23","first-page":"553","volume-title":"Pharmacology","author":"HP Rang","year":"2012","unstructured":"Rang HP, Dale MM, Ritter JM, Henderson G. Pharmacology. 7th ed. Elsevier Churchill Livingstone; 2012. p. 553\u201382.","edition":"7th ed"},{"key":"2054_CR24","doi-asserted-by":"crossref","unstructured":"Kuepper R, Skinbjerg M, Abi-Dargham A. The dopamine dysfunction in schizophrenia revisited: new insights into topography and course. In: Current antipsychotics. 2012. p. 1\u201326.","DOI":"10.1007\/978-3-642-25761-2_1"},{"key":"2054_CR25","doi-asserted-by":"publisher","first-page":"190","DOI":"10.5005\/jp\/books\/10941","volume-title":"Textbook of pharmacology for dental and allied health sciences","author":"P Udaykumar","year":"2007","unstructured":"Udaykumar P. Textbook of pharmacology for dental and allied health sciences. 2nd ed. New Delhi: Jaypee Brothers, Medical Publishers (P) LTD; 2007. p. 190\u2013200.","edition":"2nd ed"},{"key":"2054_CR26","doi-asserted-by":"publisher","unstructured":"Das M, Sarma A, Baruah H, Basak D. Insight into central nervous system targeted nanostructured lipid carriers via the nose to brain pathway. RSC Pharmaceutics. 2024(5). https:\/\/doi.org\/10.1039\/d4pm00057a.","DOI":"10.1039\/d4pm00057a"},{"key":"2054_CR27","first-page":"501","volume-title":"Basic & clinical Pharmacology","author":"BG Katzungn","year":"2012","unstructured":"Katzungn BG, Masters SB, Trevor AJ. Basic & clinical Pharmacology. 12th ed. Mc Graw Hill, Lange; 2012. p. 501\u201319.","edition":"12th ed"},{"key":"2054_CR28","first-page":"435","volume-title":"Essentials of Medical Pharmacology","author":"KD Tripathi","year":"2013","unstructured":"Tripathi KD. Essentials of Medical Pharmacology. 7th ed. New Delhi: Jaypee brothers medical publishers (p) LTD; 2013. p. 435\u201353.","edition":"7th ed"},{"issue":"12","key":"2054_CR29","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.3390\/pharmaceutics13122049","volume":"13","author":"D Lee","year":"2021","unstructured":"Lee D, Minko T. Nanotherapeutics for nose-to-brain drug delivery: an approach to bypass the blood brain barrier. Pharmaceutics. 2021Nov 30;13(12):2049.","journal-title":"Pharmaceutics"},{"issue":"1","key":"2054_CR30","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.brainresbull.2022.09.017","volume":"190","author":"S Zhang","year":"2022","unstructured":"Zhang S, Gan L, Cao F, Wang H, Gong P, Ma C, et al. The barrier and interface mechanisms of the brain barrier, and brain drug delivery. Brain Res Bull. 2022;190(1):69\u201383.","journal-title":"Brain Res Bull"},{"issue":"12","key":"2054_CR31","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.3390\/biomedicines9121834","volume":"9","author":"A Achar","year":"2021","unstructured":"Achar A, Myers R, Ghosh C. Drug delivery challenges in brain disorders across the blood\u2013brain barrier: novel methods and future considerations for improved therapy. Biomedicines. 2021Dec 4;9(12):1834.","journal-title":"Biomedicines"},{"issue":"2","key":"2054_CR32","first-page":"252","volume":"6","author":"A Misra","year":"2003","unstructured":"Misra A, Ganesh S, Shahiwala A, Shah SP. Drug delivery to the central nervous system: a review. J Pharm Pharm Sci. 2003May 1;6(2):252\u201373.","journal-title":"J Pharm Pharm Sci"},{"key":"2054_CR33","unstructured":"Patel Z, Patel B, Patel S, Pardeshi C. Nose to brain targeted drug delivery bypassing the blood-brain barrier: an overview.\u00a0Drug Inven Today.\u00a02012;4(12):610\u2013615."},{"issue":"1","key":"2054_CR34","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2174\/1574885512666170921145204","volume":"13","author":"RS Hirlekar","year":"2018","unstructured":"Hirlekar RS, Momin AM. Advances in drug delivery from nose to brain: an overview. Current Drug Therapy. 2018Apr 1;13(1):4\u201324.","journal-title":"Current Drug Therapy"},{"issue":"5","key":"2054_CR35","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.3390\/pharmaceutics14051073","volume":"14","author":"J Tai","year":"2022","unstructured":"Tai J, Han M, Lee D, Park IH, Lee SH, Kim TH. Different methods and formulations of drugs and vaccines for nasal administration. Pharmaceutics. 2022May 17;14(5):1073.","journal-title":"Pharmaceutics"},{"issue":"1","key":"2054_CR36","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2174\/187221108783331429","volume":"2","author":"A Misra","year":"2008","unstructured":"Misra A, Jogani V, Jinturkar K, Vyas T. Recent patents review on intranasal administration for CNS drug delivery. Recent Pat Drug Delivery Formulation. 2008Jan 1;2(1):25\u201340.","journal-title":"Recent Pat Drug Delivery Formulation"},{"key":"2054_CR37","doi-asserted-by":"crossref","unstructured":"Alexander A, Agrawal M, Chougule MB, Saraf S, Saraf S. Nose-to-brain drug delivery: an alternative approach for effective brain drug targeting. Nanopharmaceuticals. Elsevier. 2020. pp. 175\u2013200.\u00a0","DOI":"10.1016\/B978-0-12-817778-5.00009-9"},{"issue":"195","key":"2054_CR38","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.lfs.2017.12.025","volume":"15","author":"TP Crowe","year":"2018","unstructured":"Crowe TP, Greenlee MH, Kanthasamy AG, Hsu WH. Mechanism of intranasal drug delivery directly to the brain. Life Sci. 2018Feb;15(195):44\u201352.","journal-title":"Life Sci"},{"issue":"4","key":"2054_CR39","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.3390\/ijms24043390","volume":"24","author":"E Marcello","year":"2023","unstructured":"Marcello E, Chiono V. Biomaterials-enhanced intranasal delivery of drugs as a direct route for brain targeting. Int J Mol Sci. 2023Feb 8;24(4):3390.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2054_CR40","first-page":"16","volume":"3","author":"S Savale","year":"2017","unstructured":"Savale S, Mahajan H. Nose to brain: a versatile mode of drug delivery system. Asian J Biomater Res. 2017;3(1):16\u201338.","journal-title":"Asian J Biomater Res"},{"issue":"2","key":"2054_CR41","doi-asserted-by":"publisher","first-page":"67","DOI":"10.22159\/ijap.2021v13i2.40404","volume":"13","author":"S Chattopadhyay","year":"2021","unstructured":"Chattopadhyay S, Das SU, Sarma KN. Nose-to-brain drug delivery: an update to the alternative path to successful targeted antimigraine drugs. Int J Appl Pharm. 2021;13(2):67\u201375.","journal-title":"Int J Appl Pharm"},{"issue":"7","key":"2054_CR42","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.addr.2011.11.002","volume":"64","author":"JJ Lochhead","year":"2012","unstructured":"Lochhead JJ, Thorne RG. Intranasal delivery of biologics to the central nervous system. Adv Drug Deliv Rev. 2012;64(7):614\u201328.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"2054_CR43","doi-asserted-by":"publisher","first-page":"168","DOI":"10.4103\/jrptps.JRPTPS_59_19","volume":"9","author":"A Thakur","year":"2020","unstructured":"Thakur A, Singh PK, Biswal SS, Kumar N, Jha CB, Singh G, et al. Drug delivery through nose: A noninvasive technique for brain targeting. Journal of Reports in Pharmaceutical Sciences. 2020Jan 1;9(1):168\u201375.","journal-title":"Journal of Reports in Pharmaceutical Sciences"},{"key":"2054_CR44","doi-asserted-by":"crossref","unstructured":"Liu Q, Zhang Q. Nanoparticle systems for nose-to-brain delivery. InBrain targeted drug delivery system. Academic Press. 2019. pp. 219\u2013239.\u00a0","DOI":"10.1016\/B978-0-12-814001-7.00010-X"},{"key":"2054_CR45","doi-asserted-by":"crossref","unstructured":"Quinn Jr MJ, Ziolkowski Jr D. Wildlife toxicity assessment for triacetin. InWildlife toxicity assessments for chemicals of military concern. Elsevier; 2015. pp. 291\u2013301.\u00a0","DOI":"10.1016\/B978-0-12-800020-5.00017-X"},{"issue":"7","key":"2054_CR46","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s40263-022-00930-4","volume":"36","author":"A Lofts","year":"2022","unstructured":"Lofts A, Abu-Hijleh F, Rigg N, Mishra RK, Hoare T. Using the intranasal route to administer drugs to treat neurological and psychiatric illnesses: rationale, successes, and future needs. CNS Drugs. 2022;36(7):739\u201370.","journal-title":"CNS Drugs"},{"key":"2054_CR47","doi-asserted-by":"crossref","unstructured":"Kosaka T, Kosaka K. Olfactory bulb anatomy. In: Encyclopedia of neuroscience. 2009. p. 59\u201369.","DOI":"10.1016\/B978-008045046-9.01686-7"},{"issue":"29","key":"2054_CR48","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.neuroscience.2011.06.016","volume":"192","author":"AV Masurkar","year":"2011","unstructured":"Masurkar AV, Chen WR. Calcium currents of olfactory bulb juxtaglomerular cells: profile and multiple conductance plateau potential simulation. Neuroscience. 2011;192(29):231\u201346.","journal-title":"Neuroscience"},{"issue":"8","key":"2054_CR49","first-page":"2088","volume":"46","author":"K Selvaraj","year":"2018","unstructured":"Selvaraj K, Gowthamarajan K, Karri VV. Nose to brain transport pathways an overview: Potential of nanostructured lipid carriers in nose to brain targeting. Artificial cells, nanomedicine, and biotechnology. 2018Nov 17;46(8):2088\u201395.","journal-title":"Artificial cells, nanomedicine, and biotechnology"},{"issue":"4","key":"2054_CR50","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1002\/jps.21924","volume":"99","author":"SV Dhuria","year":"2010","unstructured":"Dhuria SV, Hanson LR, Frey WH II. Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J Pharm Sci. 2010Apr 1;99(4):1654\u201373.","journal-title":"J Pharm Sci"},{"issue":"1","key":"2054_CR51","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1517\/17425247.2012.636801","volume":"9","author":"S Bahadur","year":"2012","unstructured":"Bahadur S, Pathak K. Physicochemical and physiological considerations for efficient nose-to-brain targeting. Expert Opin Drug Deliv. 2012Jan 1;9(1):19\u201331.","journal-title":"Expert Opin Drug Deliv"},{"issue":"1\u20132","key":"2054_CR52","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/0006-8993(95)00637-6","volume":"692","author":"RG Thorne","year":"1995","unstructured":"Thorne RG, Emory CR, Ala TA, Frey WH II. Quantitative analysis of the olfactory pathway for drug delivery to the brain. Brain Res. 1995Sep 18;692(1\u20132):278\u201382.","journal-title":"Brain Res"},{"issue":"5","key":"2054_CR53","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.drudis.2019.03.021","volume":"24","author":"Z Karami","year":"2019","unstructured":"Karami Z, Zanjani MR, Hamidi M. Nanoemulsions in CNS drug delivery: recent developments, impacts and challenges. Drug Discovery Today. 2019May 1;24(5):1104\u201315.","journal-title":"Drug Discovery Today"},{"issue":"17","key":"2054_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11020084","volume":"11","author":"MC Bonferoni","year":"2019","unstructured":"Bonferoni MC, Rossi S, Sandri G, Ferrari F, Gavini E, Rassu G, et al. Nanoemulsions for \u201cNose-to-Brain\u201d drug delivery. Pharmaceutics. 2019;11(17):84. https:\/\/doi.org\/10.3390\/pharmaceutics11020084.","journal-title":"Pharmaceutics"},{"key":"2054_CR55","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.2147\/IJN.S439181","volume":"31","author":"J Koo","year":"2024","unstructured":"Koo J, Lim C, Oh KT. Recent advances in intranasal administration for brain-targeting delivery: a comprehensive review of lipid-based nanoparticles and stimuli-responsive gel formulations. Int J Nanomedicine. 2024;31:1767\u2013807.","journal-title":"Int J Nanomedicine"},{"issue":"5","key":"2054_CR56","doi-asserted-by":"publisher","first-page":"46","DOI":"10.9734\/irjpac\/2023\/v24i5824","volume":"24","author":"MG Raju","year":"2023","unstructured":"Raju MG, Edunoori K, Papani J. Nano emulsion: the targeted drug delivery in the therapy of epilepsy. Int Res J Pure Appl Chem. 2023;24(5):46\u201353.","journal-title":"Int Res J Pure Appl Chem"},{"issue":"607","key":"2054_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.121050","volume":"25","author":"D Gadhave","year":"2021","unstructured":"Gadhave D, Tupe S, Tagalpallewar A, Gorain B, Choudhury H, Kokare C. Nose-to-brain delivery of amisulpride-loaded lipid-based poloxamer-gellan gum nanoemulgel: In vitro and in vivo pharmacological studies. Int J Pharm. 2021Sep;25(607):121050.","journal-title":"Int J Pharm"},{"issue":"4","key":"2054_CR58","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/j.xphs.2021.01.021","volume":"110","author":"SA Kumbhar","year":"2021","unstructured":"Kumbhar SA, Kokare CR, Shrivastava B, Gorain B, Choudhury H. Antipsychotic potential and safety profile of TPGS-based mucoadhesive aripiprazole nanoemulsion: development and optimization for nose-to-brain delivery. J Pharm Sci. 2021Apr 1;110(4):1761\u201378.","journal-title":"J Pharm Sci"},{"issue":"30","key":"2054_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119499","volume":"586","author":"SA Kumbhar","year":"2020","unstructured":"Kumbhar SA, Kokare CR, Shrivastava B, Gorain B, Choudhury H. Preparation, characterization, and optimization of asenapine maleate mucoadhesive nanoemulsion using Box-Behnken design: in vitro and in vivo studies for brain targeting. Int J Pharm. 2020;586(30):119499.","journal-title":"Int J Pharm"},{"issue":"12","key":"2054_CR60","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.jsps.2021.11.006","volume":"29","author":"NA Abdulla","year":"2021","unstructured":"Abdulla NA, Balata GF, El-Ghamry HA, Gomaa E. Intranasal delivery of Clozapine using nanoemulsion-based in-situ gels: An approach for bioavailability enhancement. Saudi Pharmaceutical Journal. 2021Dec 1;29(12):1466\u201385.","journal-title":"Saudi Pharmaceutical Journal"},{"issue":"92","key":"2054_CR61","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ejps.2016.05.002","volume":"20","author":"DA El-Setouhy","year":"2016","unstructured":"El-Setouhy DA, Ibrahim AB, Amin MM, Khowessah OM, Elzanfaly ES. Intranasal haloperidol-loaded miniemulsions for brain targeting: evaluation of locomotor suppression and in-vivo biodistribution. Eur J Pharm Sci. 2016Sep;20(92):244\u201354.","journal-title":"Eur J Pharm Sci"},{"issue":"8","key":"2054_CR62","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1080\/10837450.2020.1772292","volume":"25","author":"MR Patel","year":"2020","unstructured":"Patel MR, Patel RB, Thakore SD, Solanki AB. Brain targeted delivery of lurasidone HCl via nasal administration of mucoadhesive nanoemulsion formulation for the potential management of schizophrenia. Pharm Dev Technol. 2020Sep 13;25(8):1018\u201330.","journal-title":"Pharm Dev Technol"},{"issue":"10","key":"2054_CR63","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1080\/10611860802476504","volume":"16","author":"M Kumar","year":"2008","unstructured":"Kumar M, Misra A, Mishra AK, Mishra P, Pathak K. Mucoadhesive nanoemulsion-based intranasal drug delivery system of olanzapine for brain targeting. J Drug Target. 2008b;16(10):806\u201314.","journal-title":"J Drug Target"},{"issue":"8","key":"2054_CR64","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1007\/s13204-016-0527-x","volume":"6","author":"MR Patel","year":"2016","unstructured":"Patel MR, Patel MH, Patel RB. Preparation and in vitro\/ex vivo evaluation of nanoemulsion for transnasal delivery of paliperidone. Appl Nanosci. 2016;6(8):1095\u2013104.","journal-title":"Appl Nanosci"},{"key":"2054_CR65","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1208\/s12249-016-0552-9","volume":"18","author":"M Boche","year":"2017","unstructured":"Boche M, Pokharkar V. Quetiapine nanoemulsion for intranasal drug delivery: evaluation of brain-targeting efficiency. AAPS PharmSciTech. 2017;18:686\u201396.","journal-title":"AAPS PharmSciTech"},{"issue":"1\u20132","key":"2054_CR66","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.ijpharm.2008.03.029","volume":"358","author":"M Kumar","year":"2008","unstructured":"Kumar M, Misra A, Babbar AK, Mishra AK, Mishra P, Pathak K. Intranasal nanoemulsion based brain targeting drug delivery system of risperidone. Int J Pharm. 2008a;358(1\u20132):285\u201391.","journal-title":"Int J Pharm"},{"issue":"6","key":"2054_CR67","doi-asserted-by":"publisher","first-page":"596","DOI":"10.2174\/156720112803529792","volume":"9","author":"S Bahadur","year":"2012","unstructured":"Bahadur S, Pathak K. Buffered nanoemulsion for nose to brain delivery of ziprasidone hydrochloride: preformulation and pharmacodynamic evaluation. Curr Drug Deliv. 2012Nov 1;9(6):596\u2013607.","journal-title":"Curr Drug Deliv"},{"key":"2054_CR68","first-page":"4301","volume":"8","author":"S Ghurghure","year":"2020","unstructured":"Ghurghure S, Khadtare JA, Dyawarkonda M, Jakune V, Khadtare A. A review of nanoemulsion: formulation approaches and application of nanoemulsion. The International Journal of Creative Research Thoughts. 2020;8:4301\u201311.","journal-title":"The International Journal of Creative Research Thoughts"},{"issue":"1","key":"2054_CR69","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/ics.12260","volume":"38","author":"MN Yukuyama","year":"2016","unstructured":"Yukuyama MN, Ghisleni DD, Pinto TD, Bou\u2010Chacra NA. Nanoemulsion: process selection and application in cosmetics\u2013a review. Int J Cosmet Sci. 2016;38(1):13\u201324.","journal-title":"Int J Cosmet Sci"},{"issue":"3","key":"2054_CR70","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3746\/pnf.2019.24.3.225","volume":"24","author":"M Kumar","year":"2019","unstructured":"Kumar M, Bishnoi RS, Shukla AK, Jain CP. Techniques for formulation of nanoemulsion drug delivery system: a review. Prev Nutr Food Sci. 2019;24(3):225.","journal-title":"Prev Nutr Food Sci"},{"issue":"1","key":"2054_CR71","volume":"287","author":"A Naseema","year":"2021","unstructured":"Naseema A, Kovooru L, Behera AK, Kumar KP, Srivastava P. A critical review of synthesis procedures, applications and future potential of nanoemulsions. Adv Colloid Interface Sci. 2021;287(1):102318.","journal-title":"Adv Colloid Interface Sci"},{"issue":"1","key":"2054_CR72","doi-asserted-by":"publisher","first-page":"187","DOI":"10.25258\/ijddt.10.1.33","volume":"10","author":"ZA Sadeq","year":"2020","unstructured":"Sadeq ZA. Review on nanoemulsion: preparation and evaluation. Int J Drug Deliv Technol. 2020;10(1):187\u20139.","journal-title":"Int J Drug Deliv Technol"},{"issue":"11","key":"2054_CR73","doi-asserted-by":"publisher","first-page":"5554","DOI":"10.5958\/0974-360X.2019.00963.6","volume":"12","author":"ZH Mahdi","year":"2019","unstructured":"Mahdi ZH, Maraie NK. Overview on nanoemulsion as a recently developed approach in drug nanoformulation. Res J Pharm Technol. 2019;12(11):5554\u201360.","journal-title":"Res J Pharm Technol"},{"issue":"1","key":"2054_CR74","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.schres.2016.11.027","volume":"184","author":"YK Katare","year":"2017","unstructured":"Katare YK, Piazza JE, Bhandari J, Daya RP, Akilan K, Simpson MJ, et al. Intranasal delivery of antipsychotic drugs. Schizophr Res. 2017;184(1):2\u201313.","journal-title":"Schizophr Res"},{"issue":"4","key":"2054_CR75","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2174\/157488410793352003","volume":"5","author":"SE Leucuta","year":"2010","unstructured":"Leucuta SE. Nanotechnology for delivery of drugs and biomedical applications. Curr Clin Pharmacol. 2010;5(4):257\u201380. https:\/\/doi.org\/10.2174\/157488410793352003.","journal-title":"Curr Clin Pharmacol"},{"issue":"4","key":"2054_CR76","first-page":"290","volume":"5","author":"C Gadiko","year":"2013","unstructured":"Gadiko C, Pamu P, Kilari EK. Effect of amiodarone on the pharmacodynamics of gliclazide in animal models. Int J Pharm Pharm Sci. 2013;5(4):290\u20133.","journal-title":"Int J Pharm Pharm Sci"},{"issue":"1","key":"2054_CR77","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ejpb.2014.05.019","volume":"88","author":"A Patil-Gadhe","year":"2014","unstructured":"Patil-Gadhe A, Pokharkar V. Montelukast loaded nanostruc tured lipid carriers: part I oral bioavailability improvement. Eur J Pharm Biopharm. 2014;88(1):160\u20138.","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"2054_CR78","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2174\/1567201053586047","volume":"2","author":"TK Vyas","year":"2005","unstructured":"Vyas TK, Shahiwala A, Marathe S, Misra A. Intranasal drug delivery for brain targeting. Curr Drug Deliv. 2005Apr;2(2):165\u201375. https:\/\/doi.org\/10.2174\/1567201053586047. (PMID: 16305417).","journal-title":"Curr Drug Deliv"},{"issue":"2e3","key":"2054_CR79","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.ejphar.2007.09.016","volume":"578","author":"JV Leite","year":"2008","unstructured":"Leite JV, Guimar~ aes FS, Moreira FA. Aripiprazole, an atypical antipsychotic, prevents the motor hyperactivity induced by psychotomimetics and psychos timulants in mice. Eur J Pharmacol. 2008;578(2e3):222\u20137.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"2054_CR80","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.neuropharm.2007.10.010","volume":"54","author":"RE Nordquist","year":"2008","unstructured":"Nordquist RE, Risterucci C, Moreau JL, et al. Effects of aripiprazole\/OPC-14597 on motor activity, pharmacological models of psychosis, and brain activity in rats. Neuropharmacology. 2008;54(2):405\u201316.","journal-title":"Neuropharmacology"},{"key":"2054_CR81","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.euroneuro.2015.01.006","volume":"25","author":"CA Oosterhof","year":"2015","unstructured":"Oosterhof CA, El Mansari M, Blier P. Asenapine alters the activity of mono aminergic systems following its subacute and long-term administration: an in vivo electrophysiological characterization. Eur Neuropsychopharmacol. 2015;25:531\u201343. https:\/\/doi.org\/10.1016\/j.euroneuro.2015.01.006.","journal-title":"Eur Neuropsychopharmacol"},{"key":"2054_CR82","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.201700295","volume":"11","author":"D Ryczko","year":"2017","unstructured":"Ryczko D, Dubuc R. Dopamine and the brainstem locomotor networks: from lamprey to human. Front Neurosci. 2017;11:295. https:\/\/doi.org\/10.3389\/fnins.201700295.","journal-title":"Front Neurosci"},{"key":"2054_CR83","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0928-0987(99)00061-5","volume":"9","author":"MI Ugwoke","year":"1999","unstructured":"Ugwoke MI, Exaud S, Mooter GD, Verbeke N, Kinget R. Bioavailabil ity of apomorphine following intranasal administration of mucoadhesive drug delivery systems in rabbits. Eur J Pharm Sci. 1999;9:213\u20139.","journal-title":"Eur J Pharm Sci"},{"key":"2054_CR84","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.colsurfb.2013.09.030","volume":"113","author":"S Sood","year":"2014","unstructured":"Sood S, Jain K, Gowthamarajan K. Optimization of curcumin nanoemulsion for intranasal delivery using design of experiment and its toxicity assessment. Colloids Surf B Biointerfaces. 2014;113:330\u20137.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"2054_CR85","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.biopha.2017.07.067","volume":"94","author":"V Pokharkar","year":"2017","unstructured":"Pokharkar V, Patil-gadhe A, Palla P. ScienceDirect efavirenz loaded nanostructured lipid carrier engineered for brain targeting through intranasal route: in-vivo pharmacokinetic and toxicity study. Biomed Pharmacother. 2017;94:150\u201364. https:\/\/doi.org\/10.1016\/j.biopha.2017.07.067.","journal-title":"Biomed Pharmacother"},{"key":"2054_CR86","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1080\/03639045.2019.1576724","volume":"45","author":"DG Gadhave","year":"2019","unstructured":"Gadhave DG, Kokare CR. Nanostructured lipid carriers engineered for in tranasal delivery of teriflunomide in multiple sclerosis: optimization and in vivo studies. Drug Dev Ind Pharm. 2019;45:839\u201351. https:\/\/doi.org\/10.1080\/03639045.2019.1576724.","journal-title":"Drug Dev Ind Pharm"},{"key":"2054_CR87","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/10667857.2019.1674522","volume":"35","author":"CV Pardeshi","year":"2020","unstructured":"Pardeshi CV, Belgamwar VS. Improved brain pharmacokinetics following in tranasal administration of N, N, N-trimethyl chitosan tailored mucoadhesive NLCs. Mater Technol. 2020;35:249\u201366. https:\/\/doi.org\/10.1080\/10667857.2019.1674522.","journal-title":"Mater Technol"},{"issue":"12","key":"2054_CR88","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.1016\/j.actbio.2011.07.025","volume":"7","author":"U Seju","year":"2011","unstructured":"Seju U, Kumar A, Sawant KK. Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in vitro and in vivo studies. Acta Biomater. 2011;7(12):4169\u201376. https:\/\/doi.org\/10.1016\/j.actbio.2011.07.025.","journal-title":"Acta Biomater"},{"key":"2054_CR89","doi-asserted-by":"publisher","unstructured":"Agu RU, Ugwoke MI. In Situ and Ex Vivo Nasal Models for Preclinical Drug Development Studies. In: Drug Absorption Studies. Springer US; 2007. p. 112\u201334. https:\/\/doi.org\/10.1007\/978-0-387-74901-3_5.","DOI":"10.1007\/978-0-387-74901-3_5"},{"key":"2054_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2019.101301","volume":"54","author":"H Choudhury","year":"2019","unstructured":"Choudhury H, Zakaria NFB, Tilang PAB, et al. Formulation development and evaluation of rotigotine mucoadhesive nanoemulsion for intranasal delivery. J Drug Deliv Sci Technol. 2019;101301. https:\/\/doi.org\/10.1016\/j.jddst.2019.101301.","journal-title":"J Drug Deliv Sci Technol"},{"key":"2054_CR91","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.apsb.2014.02.002","volume":"4","author":"R Pathak","year":"2014","unstructured":"Pathak R, Prasad Dash R, Misra M, Nivsarkar M. Role of mucoadhesive polymers in enhancing delivery of nimodipine microemulsion to brain via intranasal route. Acta Pharm Sin B. 2014;4:151\u201360. https:\/\/doi.org\/10.1016\/j.apsb.2014.02.002.","journal-title":"Acta Pharm Sin B"},{"key":"2054_CR92","doi-asserted-by":"publisher","DOI":"10.1007\/s13205-019-1885-3","volume":"9","author":"N Ahmad","year":"2019","unstructured":"Ahmad N, Ahmad R, Al-Qudaihi A, Alaseel SE, Fita IZ, Khalid MS, et al. A novel self-nanoemulsifying drug delivery system for curcumin used in the treatment of wound healing and inflammation. 3 Biotech. 2019;9:360.","journal-title":"3 Biotech"},{"issue":"19","key":"2054_CR93","doi-asserted-by":"publisher","first-page":"9214","DOI":"10.1073\/pnas.1900802116","volume":"116","author":"AP Carpenter","year":"2019","unstructured":"Carpenter AP, Tran E, Altman RM, Richmond GL. Formation and surface stabilizing contributions to bare nanoemulsions created with negligible surface charge. Proc Natl Acad Sci U S A. 2019;116(19):9214\u20139. https:\/\/doi.org\/10.1073\/pnas.1900802116.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2054_CR94","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ijpharm.2008.11.014","volume":"370","author":"H Sonja","year":"2009","unstructured":"Sonja H, Andrea S, Valenta C. Lecithin based nanoemulsion a comparative study of the influence of non-ionic surfactants and the cationic phytosphingosine on physiological behaviour and skin. Int J Pharm. 2009;370:181\u20136.","journal-title":"Int J Pharm"},{"issue":"1","key":"2054_CR95","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0378-5173(98)00054-4","volume":"167","author":"SM Khoo","year":"1998","unstructured":"Khoo SM, Humberstone AJ, Porter CJ, Edwards GA, Charman WN. Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine. Int J Pharm. 1998;167(1):155\u201364. https:\/\/doi.org\/10.1016\/S0378-5173(98)00054-4.","journal-title":"Int J Pharm"},{"issue":"4","key":"2054_CR96","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1208\/s12249-012-9847-7","volume":"13","author":"S Singh","year":"2012","unstructured":"Singh S, Pathak K, Bali V. Product development studies on surface-adsorbed nanoemulsion of olmesartan medoxomil as a capsular dosage form. AAPS PharmSciTech. 2012;13(4):1212\u201321. https:\/\/doi.org\/10.1208\/s12249-012-9847-7.","journal-title":"AAPS PharmSciTech"},{"key":"2054_CR97","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1080\/13102818.2019.1620124","volume":"33","author":"NH Che Marzuki","year":"2019","unstructured":"Che Marzuki NH, Wahab RA, Abdul Hamid M. An overview of nanoemulsion: concepts of development and cosmeceutical applications. Biotechnol Biotechnol Equip. 2019;33:779\u201397. https:\/\/doi.org\/10.1080\/13102818.2019.1620124.","journal-title":"Biotechnol Biotechnol Equip"},{"issue":"3","key":"2054_CR98","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1208\/s12249-009-9268-4","volume":"10","author":"HO Ammar","year":"2009","unstructured":"Ammar HO, Salama HA, Ghorab M, Mahmoud AA. Nanoemulsion as a potential ophthalmic delivery system for dorzolamide hydrochloride. AAPS PharmSciTech. 2009;10(3):808\u201319. https:\/\/doi.org\/10.1208\/s12249-009-9268-4.","journal-title":"AAPS PharmSciTech"},{"key":"2054_CR99","doi-asserted-by":"publisher","unstructured":"Li X, Xie K, Jiang HM. Transmission properties of guiding band in one-dimensional slow wave structures.\u00a0Proceedings of 2011 International Conference on Electronic & Mechanical Engineering and Information Technology,\u00a0Harbin, China, 2011, pp. 1313\u20131316.\u00a0https:\/\/doi.org\/10.1109\/EMEIT.2011.6023335.","DOI":"10.1109\/EMEIT.2011.6023335"},{"key":"2054_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.ces.2020.115621","volume":"220","author":"Z Wang","year":"2020","unstructured":"Wang Z, Liu H, Zhang Z, Sun B, Zhang J, Lou W. Research on the effects of liquid viscosity on droplet size in vertical gas\u2013liquid annular flows. Chem Eng Sci. 2020;220:115621. https:\/\/doi.org\/10.1016\/j.ces.2020.115621.","journal-title":"Chem Eng Sci"},{"issue":"8","key":"2054_CR101","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25081929","volume":"25","author":"SU Islam","year":"2020","unstructured":"Islam SU, Shehzad A, Ahmed MB, Lee YS. Intranasal delivery of nanoformulations: a potential way of treatment for neurological disorders. Molecules. 2020;25(8):1929. https:\/\/doi.org\/10.3390\/molecules25081929.","journal-title":"Molecules"},{"key":"2054_CR102","doi-asserted-by":"publisher","unstructured":"Illum L. Nasal drug delivery: new developments and strategies. Drug Discovery Today. 2002;7(23):1184\u20131189. ISSN 1359\u20136446.\u00a0https:\/\/doi.org\/10.1016\/S1359-6446(02)02529-1.","DOI":"10.1016\/S1359-6446(02)02529-1"},{"key":"2054_CR103","doi-asserted-by":"publisher","unstructured":"Koo J, Lim C, Oh KT. Recent advances in intranasal administration for brain-targeting delivery: a comprehensive review of lipid based nanoparticles and stimuli-responsive gel formulations. Int J Nanomed. 2024;1767\u20131807.\u00a0https:\/\/doi.org\/10.2147\/IJN.S439181","DOI":"10.2147\/IJN.S439181"},{"issue":"11","key":"2054_CR104","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17081041","volume":"17","author":"HM Yang","year":"2025","unstructured":"Yang HM. Overcoming the blood\u2013brain barrier: advanced strategies in targeted drug delivery for neurodegenerative diseases. Pharmaceutics. 2025;17(11):1041. https:\/\/doi.org\/10.3390\/pharmaceutics17081041.","journal-title":"Pharmaceutics"},{"issue":"4","key":"2054_CR105","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.apsb.2021.02.012","volume":"11","author":"CP Costa","year":"2021","unstructured":"Costa CP, Moreira JN, Sousa Lobo JM, Silva AC. Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: a current overview of in vivo studies. Acta Pharm Sin B. 2021;11(4):925\u201340. https:\/\/doi.org\/10.1016\/j.apsb.2021.02.012.","journal-title":"Acta Pharm Sin B"},{"issue":"36","key":"2054_CR106","doi-asserted-by":"publisher","first-page":"24650","DOI":"10.1021\/acsnano.3c10797","volume":"18","author":"Z Bai","year":"2024","unstructured":"Bai Z, Wan D, Lan T, Hong W, Dong H, Wei Y, et al. Nanoplatform based intranasal vaccines: current progress and clinical challenges. ACS Nano. 2024;18(36):24650\u201381. https:\/\/doi.org\/10.1021\/acsnano.3c10797.","journal-title":"ACS Nano"},{"key":"2054_CR107","doi-asserted-by":"publisher","unstructured":"Handa M, Tiwari S, Yadav AK, Almalki WH, Alghamdi S, Alharbi KS, Shukla R, Beg S.\u00a0Therapeutic potential of nanoemulsions as feasible wagons for targeting Alzheimer\u2019s disease. Drug Discov Today. 2021;26(12):2881\u20132888. ISSN 1359\u20136446.\u00a0https:\/\/doi.org\/10.1016\/j.drudis.2021.07.020.","DOI":"10.1016\/j.drudis.2021.07.020"},{"key":"2054_CR108","doi-asserted-by":"publisher","unstructured":"Makidon PE, Belyakov IM, Blanco LP, Janczak KW, Landers J, Bielinska AU, et al. Nanoemulsion mucosal adjuvant uniquely activates cytokine production by nasal ciliated epithelium and induces dendritic cell trafficking. Eur J Immunol. 2012;42(8):2073\u201386. https:\/\/doi.org\/10.1002\/eji.201142346.","DOI":"10.1002\/eji.201142346"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02054-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-026-02054-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02054-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T14:03:28Z","timestamp":1788357808000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-026-02054-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":109,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["2054"],"URL":"https:\/\/doi.org\/10.1007\/s13346-026-02054-4","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"assertion":[{"value":"3 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. No individual participant data or images are included in this review.","order":1,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This review paper does not report original research involving human participants, human data, or human tissue.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}